Amaris Natalia Rojas, Marenco-Flores Ana, Barba Romelia, Rubio-Cruz Denisse, Medina-Morales Esli, Goyes Daniela, Saberi Behnam, Patwardhan Vilas, Bonder Alan
Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Department of Internal Medicine, Texas Tech University System, Lubbock, TX 79430, USA.
J Clin Med. 2024 Nov 5;13(22):6642. doi: 10.3390/jcm13226642.
: Acute liver failure (ALF) involves rapid liver injury, often leading to multi-organ failure. Liver transplantation (LT) has improved survival rates, with U.S. rates reaching 92%. This study analyzes UNOS data (2002-2020) to evaluate long-term survival and identify risk factors affecting waitlist and post-LT outcomes in ALF patients. : A retrospective analysis was performed on adult ALF patients waitlisted for LT (Status 1/1A). ALF etiologies, including viral infections, drug-induced liver injury (DILI), acetaminophen (APAP) overdose, autoimmune hepatitis (AIH), Wilson disease (WD), and unknown causes, were assessed with patient and donor characteristics. Kaplan-Meier and Cox regression analyses identified predictors of patient and graft survival. Sensitivity analysis confirmed the model's robustness. : We identified 2759 ALF patients. APAP (HR 1.7; < 0.001) and unknown etiology (HR 1.3; = 0.037) were linked to higher waitlist removal risk, while WD (HR 0.36; < 0.001) increased LT probability. Among 2014 LT recipients, WD showed improved survival (HR 0.53; = 0.002). Black/African American race (HR 1.47; < 0.001), diabetes (HR 1.81; < 0.001), and encephalopathy (HR 1.27; < 0.001) predicted higher mortality. AIH had the lowest 1- and 10-year survival (83% and 62%), while APAP had the lowest 5-year survival (76%). WD had the highest graft survival at 1, 5, and 10 years (93%, 88%, and 80%). : ALF etiology significantly affects survival outcomes. AIH and APAP are associated with worse survival, while WD shows favorable outcomes. Tailored post-LT management is essential to improve survival in ALF patients.
急性肝衰竭(ALF)涉及肝脏的快速损伤,常导致多器官功能衰竭。肝移植(LT)提高了生存率,美国的生存率达到了92%。本研究分析了器官共享联合网络(UNOS)的数据(2002 - 2020年),以评估长期生存率,并确定影响ALF患者等待名单和肝移植后结局的风险因素。
对列入肝移植等待名单(状态1/1A)的成年ALF患者进行了回顾性分析。评估了ALF的病因,包括病毒感染、药物性肝损伤(DILI)、对乙酰氨基酚(APAP)过量、自身免疫性肝炎(AIH)、威尔逊病(WD)以及不明原因,并分析了患者和供体的特征。采用Kaplan - Meier和Cox回归分析确定患者和移植物存活的预测因素。敏感性分析证实了模型的稳健性。
我们确定了2759例ALF患者。APAP(风险比[HR] 1.7;P < 0.001)和不明病因(HR 1.3;P = 0.037)与等待名单上被移除的风险较高相关,而WD(HR 0.36;P < 0.001)增加了肝移植的可能性。在2014例肝移植受者中,WD显示出较好的生存率(HR 0.53;P = 0.002)。黑人/非裔美国人种(HR 1.47;P < 0.001)、糖尿病(HR 1.81;P < 0.001)和肝性脑病(HR 1.27;P < 0.001)预示着更高的死亡率。AIH的1年和10年生存率最低(分别为83%和62%),而APAP的5年生存率最低(76%)。WD在1年、5年和10年的移植物存活率最高(分别为93%、88%和80%)。
ALF的病因显著影响生存结局。AIH和APAP与较差的生存率相关,而WD显示出良好的结局。定制肝移植后的管理对于提高ALF患者的生存率至关重要。